Presentation TCT 2017 FDA Perspectives on Short DAPT IDE Trials Presenter: Mitchell W. Krucoff, P.F. Adrian Magee October 31, 2017
Presentation TCT 2017 TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu October 31, 2017
Presentation TCT 2017 The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Ajay J. Kirtane October 31, 2017
Presentation TCT 2017 TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman October 31, 2017
Presentation TCT 2017 The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice October 31, 2017
Presentation TCT 2017 Reasonable and Unreasonable Bifurcations for Bioresorbable Scaffolds, and Technique (With Case Examples) Presenter: Antonio Colombo, Manuel Pan, Jens Flensted Lassen October 30, 2017
Presentation TCT 2017 Bioresorbable Scaffolds in Complex SFA Lesions: Case Examples and Data Presenter: Subhash Banerjee, Tony Das October 30, 2017
Presentation TCT 2017 Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease? Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois October 30, 2017
Presentation TCT 2017 Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Rajiv Ananthakrishna October 30, 2017
Presentation TCT 2017 Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta October 30, 2017
Presentation TCT 2017 Case #6: How to Implant Bioresorbable Scaffolds in Diffuse Disease (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta October 30, 2017
Presentation TCT 2017 Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Antonio Colombo October 30, 2017
Presentation TCT 2017 Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Daniel Chamie October 30, 2017
Presentation TCT 2017 Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Alessio G La Manna October 30, 2017
Presentation TCT 2017 Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Javier Suárez de Lezo October 30, 2017
Presentation TCT 2017 Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion) Presenter: Stephan Achenbach, Salvatore Brugaletta, Petr Tousek October 30, 2017
Presentation TCT 2017 Bioresorbable Scaffolds in a Coronary CTO Presenter: Teguh Santoso, Yoshito Yamamoto October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds? Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach October 30, 2017
Presentation TCT 2017 Next Generation BRS Platforms Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung October 29, 2017
Presentation TCT 2017 Bioresorbable Scaffolds and Outcomes 2017 Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle October 29, 2017